|
FDA Removes Restrictions on Boston Scientific
The FDA informed Boston Scientific that the company is in “substantial compliance” regarding its quality systems, and the only remaining hurdle to getting its corporate warning letter lifted is remediation of medical device reporting (MDR) issues, according to the company’s CEO.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives